Gancotamab
From EverybodyWiki Bios & Wiki
Monoclonal antibody | |
---|---|
Type | Single-chain variable fragment |
Source | Human |
Target | ERBB2 |
Clinical data | |
Synonyms | MM-302 |
ATC code |
|
Identifiers | |
CAS Number | |
UNII | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}} |
Chemical and physical data | |
Molar mass | 25.8 g/mol |
Gancotamab (MM-302) (INN) is an antibody fragment designed for the treatment of cancer.[1][2]
This drug is being developed by Merrimack Pharmaceuticals.
References[edit]
This monoclonal antibody–related article is a stub. You can help EverybodyWiki by expanding it. |
This article "Gancotamab" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Gancotamab. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.